BioSpace News Archive

Amgen’s Migraine Drug Heads Toward Possible May Approval

Amgen announced final data from its Phase IIIb LIBERTY clinical trial of Aimovig (erenumab), with positive results likely to lead to a blockbuster drug for migraine sufferers.

April 18, 2018

·

3 min read

·

Mark Terry

Soft focus nurses are vaccinations to patients using the syringe.Doctor vaccinating women in hospital.Are treated by the use of sterile injectable upper arm. injection

BioMidwest

Merck and NewLink’s Ebola Vaccine Leads the Pack in Offering Longest Protection

Public health officials and scientists have had concerns about how long Ebola vaccines’ protection lasts. A new study shows that one of those vaccines confers at least two years of protection.

April 18, 2018

·

3 min read

·

Mark Terry

Drug Development

PharmaCannis Takes Biopharma Approach to Medical Marijuana

It seems inevitable that as marijuana becomes more broadly legal in the U.S., that the biopharma industry and larger corporations will take an interest.

April 18, 2018

·

3 min read

·

Mark Terry

Business

1Q2018 Earnings Call Highlights Abbott’s $7.4 Billion In Sales

Abbott today announced financial results for the first quarter ending March 31, 2018 and is off to a strong start to the year.

April 18, 2018

·

3 min read

·

Don McCormick

Policy

FDA Commissioner Goes to Bat for the BioPharma Industry

During a meeting with U.S. Food and Drug Administration Commissioner Scott Gottlieb earlier this week, government and healthcare officials in New Jersey highlighted the need to hasten the approval of new drugs and permanently eliminate the tax on medical devices.

April 18, 2018

·

3 min read

·

Alex Keown

Drug Development

AACR Meeting Brief: Sosei, Verseon, Rgenix, Xencor and others

The 2018 American Association for Cancer Research (AACR) is being held in Chicago. Here’s a roundup of some of today’s company news.

April 18, 2018

·

4 min read

·

Mark Terry

Business

Eli Lilly Shows Off More Verzenio Data at AACR

Nearly two months after Eli Lilly secured an expanded approval indication for its cancer drug Verzenio, the company unveiled final data from the MONARCH 3 trial that won the latest nod from the U.S. Food and Drug Administration for the treatment of some breast cancer patients.

April 18, 2018

·

3 min read

·

Alex Keown

Woman celebrating her goals. Successful concept.

Business

GSK Recruiting Score: Genentech’s Kevin Sin to Help Drive R&D and M&A

GlaxoSmithKline Chief Executive Officer Emma Walmsley continues to hone her leadership team with a hire who will focus on potential research and development deals.

April 18, 2018

·

2 min read

·

Alex Keown

The Top 3 Skills Scientists Should Develop to Land a Job Outside of Academia

Many scientists spend countless hours applying for full-time positions at colleges and universities only to experience the sting of rejection. Overall, less than half of life science professionals with doctorate degrees work in academia.

April 18, 2018

·

4 min read

·

Porschia Parker

Policy

The Growing Legal Battles Against Opioid Manufacturers

Utah’s Salt Lake County is the latest governing body to enter the legal battle against opioid manufacturers, distributors and prescribers. Governments are seeking financial restitution for the funds they have spent on battling addiction to prescription opioid medications.

April 18, 2018

·

3 min read

·

Alex Keown